lobbying_activities: 1516161
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1516161 | 914bbe5c-9746-47d6-80a9-0051b9002b45 | Q1 | BROWN RUDNICK LLP | 287895 | PRIME THERAPEUTICS | 2014 | first_quarter | PHA | Issues relating to generic pharmaceutical utilization | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2014-04-15T10:44:50.013000-04:00 |